Sponsor Pipeline

Shenzhen Genocury Biotech Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
4
Disease Areas
Active Trials by Phase
Early Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07336823 JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma Multiple Myeloma Recruiting
Not specified
NCT06678282 JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/… B-NHL Recruiting
NCT06890065 JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia B Acute Lymphoblastic Leukemia Recruiting
Disease Areas
Acute Lymphoblastic Leukemia (ALL) (2) Non-Hodgkin Lymphoma (2) Leukemia (1) Multiple Myeloma (1)
Get alerts when Shenzhen Genocury Biotech Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free